JP2019506390A5 - - Google Patents

Download PDF

Info

Publication number
JP2019506390A5
JP2019506390A5 JP2018537799A JP2018537799A JP2019506390A5 JP 2019506390 A5 JP2019506390 A5 JP 2019506390A5 JP 2018537799 A JP2018537799 A JP 2018537799A JP 2018537799 A JP2018537799 A JP 2018537799A JP 2019506390 A5 JP2019506390 A5 JP 2019506390A5
Authority
JP
Japan
Prior art keywords
vaccine
hapten
class drug
fentanyl class
vivo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018537799A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019506390A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/013865 external-priority patent/WO2017127390A1/en
Publication of JP2019506390A publication Critical patent/JP2019506390A/ja
Publication of JP2019506390A5 publication Critical patent/JP2019506390A5/ja
Pending legal-status Critical Current

Links

JP2018537799A 2016-01-21 2017-01-18 合成オピオイドワクチン Pending JP2019506390A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662281262P 2016-01-21 2016-01-21
US62/281,262 2016-01-21
PCT/US2017/013865 WO2017127390A1 (en) 2016-01-21 2017-01-18 Synthetic opioid vaccine

Publications (2)

Publication Number Publication Date
JP2019506390A JP2019506390A (ja) 2019-03-07
JP2019506390A5 true JP2019506390A5 (https=) 2020-02-27

Family

ID=59362842

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018537799A Pending JP2019506390A (ja) 2016-01-21 2017-01-18 合成オピオイドワクチン

Country Status (7)

Country Link
US (1) US11305010B2 (https=)
EP (1) EP3405475B1 (https=)
JP (1) JP2019506390A (https=)
CN (1) CN108884127A (https=)
BR (1) BR112018014908A2 (https=)
RU (1) RU2018130106A (https=)
WO (1) WO2017127390A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019094528A1 (en) 2017-11-09 2019-05-16 The Scripps Research Institute An improved heroin vaccine
WO2020006563A1 (en) * 2018-06-29 2020-01-02 Marquette University Fluorinated compounds as ph-sensitive analgesics
US20220409722A1 (en) * 2019-11-08 2022-12-29 Regents Of The University Of Minnesota Fentanyl hapten, fentanyl hapten-conjugates, and methods for making and using
WO2021146334A1 (en) * 2020-01-13 2021-07-22 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Fentanyl haptens for the preparation of a fentanyl vaccine
US20230126276A1 (en) * 2020-03-13 2023-04-27 Regents Of The University Of Minnesota Fentanyl haptens, fentanyl hapten conjugates, and methods for making and using
WO2022240898A1 (en) * 2021-05-10 2022-11-17 Cornell University Development of a highly efficient second generation fentanyl-conjugate vaccine to treat fentanyl addiction
EP4694925A2 (en) * 2023-04-13 2026-02-18 Avicenna Biotech Research, Llc Compositions and methods for treating fentanyl dependence

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283066A (en) * 1992-02-19 1994-02-01 Development Center For Biotechnology Method of stimulating an immune response by using a hapten
CA2132342A1 (en) 1992-04-06 1993-10-14 Kenneth F. Buechler Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
US6262265B1 (en) 1999-06-18 2001-07-17 Microgenics Corporation Non-hydrolyzable analogs of heroin metabolites suitable for use in immunoassay
US7109310B2 (en) * 2001-11-16 2006-09-19 Randox Laboratories, Ltd. Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs
CA2487849A1 (en) * 2002-07-18 2004-01-29 Cytos Biotechnology Ag Hapten-carrier conjugates comprising virus like particles and uses thereof
WO2004111202A2 (en) * 2003-03-07 2004-12-23 Incyte Corporation Neurotransmission-association proteins
MXPA04006617A (es) 2004-07-07 2006-01-12 Inst Nac De Psiquiatria Ramon Proceso para la preparacion y uso de una vacuna bivalente contra la adiccion a la morfina-heroina.
TR201901929T4 (tr) * 2005-02-08 2019-03-21 Genzyme Corp TGFBeta'ya antikorlar.
US20110182918A1 (en) * 2008-06-13 2011-07-28 Nabi Biopharmaceuticals Personalized drug treatment and smoking cessation kit and method
KR101047192B1 (ko) * 2009-04-15 2011-07-06 포항공과대학교 산학협력단 표적 특이적 비항체 단백질 및 이의 제조 방법
SG191716A1 (en) * 2010-11-19 2013-08-30 Toshio Imai Neutralizing anti-ccl20 antibodies
JP2015502356A (ja) * 2011-11-30 2015-01-22 ウェルスタット ダイアグノスティクス,エルエルシー 5−fuに関連するアッセイ、抗体、免疫原および組成物
CA2895702C (en) 2011-12-21 2020-03-31 The Scripps Research Institute Heroin haptens, immunoconjugates and related uses
US20140093525A1 (en) * 2012-09-17 2014-04-03 Minneapolis Medical Research Foundation Compositions and methods of treating opioid addiction
US9981043B2 (en) 2013-02-08 2018-05-29 Regents Of The University Of Minnesota Analgesic conjugates
US9213029B2 (en) * 2013-06-25 2015-12-15 Samsung Electronics Co., Ltd. Method for diagnosing breast cancer by detection of polymeric immunoglobulin receptor in vesicles isolated from patients

Similar Documents

Publication Publication Date Title
JP2019506390A5 (https=)
RU2018130106A (ru) Вакцина против синтетических опиоидов
Sulczewski et al. Nanoparticle vaccines against viral infections
JP2016516074A5 (https=)
JP2014513725A5 (https=)
JP2014515406A5 (https=)
JP6389559B2 (ja) 不活化全粒子ワクチンを含有するマイクロニードルアレイ製剤およびその投与方法
JP2013534248A5 (https=)
RU2014141545A (ru) Нацеливающие аминокислотные липиды
JP2012017342A5 (https=)
JP2006527762A5 (https=)
Zhou et al. pH-Sensitive and biodegradable Mn3 (PO4) 2· 3H2O nanoparticles as an adjuvant of protein-based bivalent COVID-19 vaccine to induce potent and broad-spectrum immunity
Crouse et al. A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models
JP2019536761A5 (https=)
Lockner et al. A conjugate vaccine using enantiopure hapten imparts superior nicotine-binding capacity
JP2018505882A5 (https=)
TWI578997B (zh) 用於預防或治療菸鹼成癮之共軛體
ES2565578T3 (es) Vacunas contra el cáncer que contienen epítopos de antígeno oncofetal
EP3823620A4 (en) OPIOID HAPTENES, CONJUGATES, VACCINES AND METHODS OF GENERATING ANTIBODIES
EA201171032A1 (ru) Схемы лечения с помощью вакцины против гриппа, связанного с пандемическими штаммами
ES2612357T3 (es) Composiciones antigénicas y métodos
Cossette et al. Intranasal subunit vaccination strategies employing nanomaterials and biomaterials
CN103768595A (zh) 唑来膦酸佐剂及含唑来膦酸佐剂的疫苗
TW201733616A (zh) 包含固定化病毒粒子之疫苗
Jacob et al. Investigations of enantiopure nicotine haptens using an adjuvanting carrier in anti-nicotine vaccine development